Company: PTPI
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001104659-25-025104
Chunk: 4

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 4
---
 Amendment to the Petros Pharmaceuticals, Inc.                                                                   
 Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended, to increase the total number of shares of the Company’s   
 Common Stock authorized for issuance under such plan by 1,000,000,000, to a total of 1,002,760,000 shares of Common Stock (“Proposal 
 3” or, the “Plan Amendment Proposal”);                                                                                               |

| 4. | To approve an amendment to the Charter to increase the number of our                                                                  
 authorized shares of Common Stock from 250,000,000 shares to 7,000,000,000 shares and to make a corresponding change to the number of 
 authorized shares of capital stock (“Proposal 4” or, the “Share Increase Proposal”); and                                              |

| 5. | To approve a proposal to adjourn the Special Meeting to a later date                                                                     
 or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes 
 for, or otherwise in connection with, the approval of any one or more of the foregoing proposals (“Proposal 5” or, the “Adjournment      
 Proposal”).                                                                                                                              |

Stockholders are referred
to the Proxy Statement for more detailed information with respect to the matters to be considered at the Special Meeting. After careful
consideration, the Board of Directors recommends a vote “FOR” Proposals 1 - 5.

Who May Vote:

Only stockholders of record
as of the close of business on February 19, 2025 (the “Record Date”) are entitled to receive notice of and to vote at
the Special Meeting and any adjournments or postponements of the meeting. Purchasers of shares of Common Stock and/or pre-funded warrants
(the “Pre-Funded Warrants”) exercisable for shares of Common Stock sold in the Offering are not entitled to vote such shares
of Common Stock or shares of Common Stock issuable upon exercise of such Pre-Funded Warrants on the Issuance Proposal.

You will be able to participate
in the virtual Special Meeting online and vote your shares electronically during the meeting. You will not be able to attend the Special
Meeting in person.

To virtually attend the Special
Meeting, you must be a stockholder of record or beneficial owner as of the close of business on the Record Date. You will be able to virtually
attend and participate in the Special Meeting by visiting www.virtualshareholder